As to the cytokines and chemokines, the changes of RANTES concentration after the neuroendocrine challenge showed no difference between the migraine (χ2(2) = 5.77, p = 0.056) and the control groups (χ2(2) = 5.77, p = 0.056) (Figure 3). The gene discussed is CCL5; the disease is migraine disorder.